Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy.

This study has been completed.
Information provided by:
Pfizer Identifier:
First received: November 19, 2008
Last updated: June 28, 2011
Last verified: June 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2009
  Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)